The comparative effectiveness of hydrochlorothiazide and chlorthalidone in an observational cohort of veterans

Journal of Clinical Hypertension

Volumn 14, Issue 9, 2012, Pages 623-629

  Lund, Brian C ^a   Ernst, Michael E ^b,c  

^a Iowa City Veterans Affairs Health Care System   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORTALIDONE; HYDROCHLOROTHIAZIDE;

ADULT; ARTICLE; CLINICAL PRACTICE; COHORT ANALYSIS; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG USE; ELECTROLYTE DISTURBANCE; FEMALE; HUMAN; HYPERTENSION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE; VETERAN;

AGED; BLOOD PRESSURE; CHLORTHALIDONE; COHORT STUDIES; COMPARATIVE EFFECTIVENESS RESEARCH; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VETERANS;

EID: 84865769635     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2012.00679.x     Document Type: Article

References (15)

1. Ernst ME, Moser M. Use of diuretics in patients with hypertension. N Engl J Med. 2009;361:2153-2164.
2. Ernst ME, Carter BL, Goerdt CJ, et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension. 2006;47:352-358.
3. Ernst ME, Carter BL, Zheng S, Grimm RH Jr. Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium. Am J Hypertens. 2010;23:440-446.
4. Dorsch MP, Gillespie BW, Erickson SR, et al. Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis. Hypertension. 2011;57:689-694.
5. Ernst ME, Neaton JD, Grimm RH Jr, et al. Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the Multiple Risk Factor Intervention Trial. Hypertension. 2011;58:1001-1007.
6. Ernst ME, Lund BC. Renewed interest in chlorthalidone: evidence from the Veterans Health Administration. J Clin Hypertens (Greenwich). 2010;12:927-934.
7. Avorn J. Transforming trial results into practice change: the final translational hurdle: comment on "Impact of the ALLHAT/JNC7 Dissemination Project on thiazide-type diuretic use." Arch Intern Med. 2010;170:858-860.
8. IOM (Institute of Medicine). Initial National Priorities for Comparative Effectiveness Research. Washington, DC: The National Academies Press; 2009.
9. Steiner JF, Koepsell TD, Fihn SD, Inui TS. A general method of compliance assessment using centralized pharmacy records. Med Care. 1998;26:814-823.
10. Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertension. 2004;43:4-9.
11. Temperini C, Cecchi A, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: sulfonamide diuretics revisited - old leads for new applications? Org Biomol Chem. 2008;6:2499-2506.
12. Woodman R, Brown C, Lockette W. Chlorthalidone decreases platelet aggregation and vascular permeability and promotes angiogenesis. Hypertension. 2010;56:463-470.
13. Egan BM, Zhao Y, Axon RN. US Trends in prevalence, awareness, treatment, and control of hypertension, 1998-2008. JAMA. 2010;303:2043-2050.
14. Stafford RS, Monti V, Furberg CD, Ma J. Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States. Hypertension. 2006;48:213-218.
15. Fishman PA, Anderson ML, Cook AJ, et al. Accuracy of blood pressure measurements reported in an electronic medical record during routine primary care visits. J Clin Hypertens (Greenwich). 2011;13:821-828.